BayPAT’s Licensee Scintomics signed Sub-License Agreement with Blue Earth Diagnostics to bring rhPSMA for Prostate Cancer to Market
BayPAT, service provider offering services in the area of technology transfer, IP management and commercialization, today announced that its licensee Scintomics has signed a sub-license and option agreement with Blue Earth Diagnostics, Ltd. In July 2017, BayPAT has out-licensed the Mehr






